Opportunity
CanadaBuys #20180316
INSPQ seeks 100 Diasorin (Luminex) NxTAG respiratory pathogen panel kits
Posted
October 30, 2026
Respond By
November 14, 2026
Identifier
20180316
NAICS
325413
The Institut national de santé publique du Québec is seeking respiratory pathogen testing kits for provincial laboratory surveillance. - Government buyer: Institut national de santé publique du Québec (INSPQ), through the Laboratoire de santé publique du Québec (LSPQ). - OEM: Diasorin (Luminex) is the named manufacturer; the notice intends a direct award to this supplier. - Product requested: 100 NxTAG Respiratory Pathogen Panel v2 (IVD-CA) kits. No part number is provided. - Each kit supports simultaneous detection of 21 respiratory pathogens. - Intended uses include influenza vaccine-effectiveness monitoring and provincial surveillance of influenza-related hospital morbidity and mortality. - Notable requirements and rationale: INSPQ cites established laboratory workflows and a lack of resources for validating and training on a replacement product. It also identifies potential incompatibilities, delays, service interruptions, and added operational costs from switching. - Opportunity status: This is an Advance Contract Award Notice and market review, not a competitive tender. Other suppliers may respond with evidence that they can meet the requirements; INSPQ may then decide whether to conduct a public tender or proceed with the intended supplier.
Description
The Institut national de santé publique du Québec (INSPQ), through the Laboratoire de santé publique du Québec (LSPQ), intends to acquire 100 NxTAG Respiratory Pathogen Panel v2 (IVD-CA) kits from Diasorin (Luminex) during 2027. Each kit enables simultaneous detection of 21 respiratory pathogens, supporting influenza vaccine-effectiveness and provincial hospital surveillance programs. This Advance Contract Award Notice is a market review, not a competitive tender; interested suppliers may respond by the deadline to demonstrate they can meet all stated requirements. The INSPQ will decide whether to launch a public tender or negotiate exclusively with the identified supplier.